3 February 2020
World cancer day: the importance of patient engagement within cancer research
- Open article for English - 4 februari is het wereldkankerdag. Erica van Wuijtswinkel, patiëntvertegenwoordiger bij de Raad van Toezicht van Oncode Institute, legt uit waarom patiëntenparticipatie zo belangrijk is binnen kankeronderzoek. Ze bespreekt ook hoe zij haar rol binnen Oncode Institute invult en hoe Oncode patiëntenparticipatie heeft ingebed in de organisatie.
26 January 2020
Oncode researchers gain access to Organoid technology thanks to collaboration with KNAW
Thanks to an agreement between the Royal Netherlands Academy of Arts and Sciences (KNAW) and Oncode Institute, the organoid technology will become available to all 800+ cancer researchers that are part of Oncode. The KNAW collaborates with its institutional partner UMC Utrecht on organoid technology. Thanks to this agreement with Oncode, researchers receive a license to conduct research on organoids for the first time in the Netherlands.
23 January 2020
Venom-producing snake organoids developed in the lab
Researchers from the group of Oncode Investigator Hans Clevers, together with Oncode Investigators Anne Rios, Alexander van Oudenaarden and many others, have developed a method to grow snake venom gland cells as organoids. These lab-grown mini glands produce and secrete active toxins found in snake venom. Snake venom gland organoids can be grown from multiple species and maintained in the lab indefinitely. This new technology holds great promise to reduce the devastating impact and exploit the secrets of snake venom. The results of this research were published in the scientific journal Cell on the 23rd of January.
10 December 2019
Oncode Investigators Elzo de Wit and Ruben van Boxtel receive ERC Grant
Oncode Institute is proud to announce that Oncode Investigators Elzo de Wit (Netherlands Cancer Institute) and Ruben van Boxtel (Princess Máxima Center) both receive the ERC Consolidator Grant. The ERC Consolidator Grants are awarded to outstanding researchers with at least seven and up to twelve years of experience after PhD, and a scientific track record showing great promise.
29 November 2019
Researchers explain the added value of Oncode Institute
At this year's Oncode-CGC Annual conference, we took the time to speak with some of our Oncode Investigators. In this video, they explain the value that Oncode adds to their research, collaboration opportinuties and valorization success.
29 November 2019
Oncode Institute invests 4 million euros in new technology for cancer research in the Netherlands
Oncode Institute invests 4 million euros in unique, state-of-the-art technology for cancer research. Five projects have been awarded within the Infrastructure & Technologies Programme. These technologies will not only become available for the twelve institutes that are affiliated with Oncode Institute but will also be made available to the wider research community in the Netherlands.
28 November 2019
Biotech Wednesday: Joining forces to outsmart cancer – new frontiers in cell therapy
United by a desire to bring new cell therapies to patients, Oncode Institute and HollandBIO brought together academia, life sciences companies, clinicians and other relevant stakeholders at this first of its kind event.
7 November 2019
Oncode is hiring!
Interested in joining us? Oncode is an independent institute dedicated to understanding cancer and translating research into practice more efficiently. Oncode, starting from a deeper understanding of the basics of cancer, works to come up with better treatments and improved diagnostics.
4 November 2019
A platform to fully exploit available clinical CRC studies
Miriam Koopman and Louis Vermeulen collaborate to improve prospects for colorectal cancer patients via Oncode's Equipment & Infrastructure Program. This program has a collaborative set-up to make equipment available throughout the community.
4 November 2019
Get the patient into the lab!
Oncode started the Patient Perspective Program. The goal of this program is to connect (ex-)patients to Oncode labs and/or individual Oncode researchers. This should decrease the distance between Oncode researchers and patients so they can explore, investigate and understand each other's worlds. Research groups from the Netherlands Cancer Institute and the LUMC are taking part in the first pilot of the Patient Perspective Program.
Scroll for more